Chronic autoimmune hepatitis following cholestatic hepatitis induced by droxicam;HEPATITIS CRONICA AUTOINMUNE DESPUES DE UNA HEPATITIS COLESTASICA INDUCIDA POR DROXICAM

Medicina Clinica

Volumn 106, Issue 12, 1996, Pages 460-462

  Perez Aguilar F ^a   Berenguer, M ^a,b   Ramirez Palanca J J ^a   Paya A ^a   Vera Sempere, F J ^a   Sanchez Cuenca J M ^a   Berenguer, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DROXICAM; PREDNISONE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINE DERIVATIVE;

AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLESTATIC HEPATITIS; DRUG HYPERSENSITIVITY; HISTOPATHOLOGY; HUMAN; MALE; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED DISORDER; CHOLESTASIS; CHRONIC DISEASE; FOLLOW UP; HEPATITIS; IMMUNOLOGY; LIVER; PATHOLOGY; TIME; TOXIC HEPATITIS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; CHOLESTASIS; CHRONIC DISEASE; FOLLOW-UP STUDIES; HEPATITIS; HEPATITIS, TOXIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; PYRIDINES; TIME FACTORS;

EID: 0029984265     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. López-Tierra G, Merino MJ, Gómez-Camacho E, Ollero M. Hepatitis tóxica por droxicam [carta] Med Clin (Barc) 1992. 98: 36-36.
2. Cancelo P, Prieto JM, De la Cueva JA, Velasco A. Hepatitis tóxica por droxicam [carta] Med Clin (Barc) 1992; 99: 238-239.
3. Caballería E, Aragó JV, Massó RM, Sanchis A Hepatitis tóxica por droxicam [carta] Med Clin (Barc) 1992; 99: 239
4. Roselló T, Fiol F. Hepatitis tóxica por droxicam [carta] Med Clin (Barc) 1992, 99: 239
5. Bertrán X, Planas R, Ojanguren I, Guillera M, Costa J, Gassull MA. Hepatitis colestásica severa por droxicam Gastroenterol Hepatol 1993; 16: 21-23
6. Alguacil GF, García B, Martínez M, De Paco M Hepatitis colestásica por droxixam Rev Clin Exp 1993, 192 94-95
7. Ariño J, Sánchez de la Fuenie MF, García-Cano J, Jiménez Sánchez F, Rosa Herranz C, Pérez Sol A et al. Hepatotoxicidad por droxicam. presentación de 4 casos Rev Esp Enf Ap Digest 1993; 83 197-201
8. Ferrer T, Martín I, Garrido M, Domínguez Madas A, Ramos Lora M, Pujol de la Llana E Hepatitis tóxica por droxicam serie de 8 casos Gastroenterol Hepatol 1994, 17 7-10
9. Acero D, Vidal L, Bruguera M, Sala M, Soler S, Tode MR et al Hepatotoxicidad por droxicam. Presentación de 11 casos Gastroenterol Hepatol 1993; 16 599-603
10. Martínez L, Sánchez L, Roser R Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) in healthy volunteers. Meth Find Exptl Clin Pharmacol 1988; 10 729-733
11. Esteve A, Martínez L, Roser R, Sagarra R. Pharmacokinetics of droxicam in rat and dog, Meth Find Exptl Clin Pharmacol 1986: 8: 423-429
12. Planas R, De León R, Quer JC, Barranco C, Bruguera M, Gasull A Fatal submassive necrosis of the liver associated with piroxicam Am J Gastroenterol 1990, 85. 468-470
13. Lee SM, O'Brien GJ, Williams R, Whitaker S, Gould SR. Subacute hepatic necrosis induced by piroxicam. Br Med J 1986; 293. 540-541
14. Caballería E, Massó RM, Aragó JV, Sanchís A. Piroxicam hepatotoxtcity. Am J Gastroenterol 1990, 85: 898-899.
15. Paterson D, Kerlin P, Walker N, Lynch S, Strong R Piroxicam induced submassive necrosis of the liver. Gut 1992, 33: 1.436-1.438.
16. Scully U, Clarke D, Barr RJ. Diclofenac induced hepatitis. 3 cases with features of autoinmune chronic active hepatitis Dig Dis Scien 1993, 38: 744-751.
17. Caruana A, Andre C, Zafrani ES, Saint-Marc Girardm MF, Metreau JM, Dhumeaux D Serum antibodies against double-stranded DNA in chronic active hepatitis: and index of drug-induced liver disease? [carta) Lancet 1983; 1: 776
18. Iveson TJ, Ryley NG, Kelly PMA, Trowell JM, McGee JOD, Chapman RWG. Diclofenac associated hepatitis J Hepatol 1990; 10. 85-89.
19. Mazeica PK, Ford MJ. Chronic active hepatitis associated with diclofenac sodium therapy. Br J Clin Proc 1989, 43: 125-126.
20. Sallie RW, Reed WD, Quinlan MF, McKenzie T, Shilkin KB. Diclofenac hepatotoxicity and chronic active hepatitis [resumen] Aust NZ J Med 1988; 18 413.
21. Rodman JS, Deutsch DJ, Gutman SI. Methyldopa hepatitis a report of six cases and review of literature Am J Med 1976; 60 941-948.
22. Black M, Mitchell JR, Zimmerman HJ, Ishak KG, Epler GR. Isoniazid-associated hepatitis in 114 patients. Gastroenterology 1975, 69: 289-302
23. Reynolds TB, Peters RL, Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 1971; 285: 813-820.
24. Bercetche M, Pérez V, Avagnina A Hepatitis crónica por oxifenisatina Medicine (ed esp) 1984; 44: 59-63
25. Sheron N, Eddleston A Hepatitis crónica activa autoinmune. En. Rodés J, Benhamou JP. Bircher J, McIntyre N, Rizzeto M, editores. Tratado de Hepatología Clínica Barcelona Masson-Salvat, 1993; 881-891
26. Meyer zum Büschenfelde K-H, Lohse AW, Manns M, Porralla T. Autoimmunity and liver disease. Hepatology 1990, 12: 354-361
27. Vierling JM. immune disorders of the liver and bile duct En. MacDermott RP, Elson Ch, editores. Gastr Clin North Am. Filadeifia: WB Saunders, 1992; 427-449
28. Vetter D, Gervais A, Habersetzer F, Uhl G, Doffoel M Hépatites auto-immunes. Nouveaux aspects physiopathologiques et cliniques Gastroenterol Clin Biol 1994, 18. 429-436
29. Maddrey WC, Boitnott JK Drug-induced chronic liver disease Hepatology 1977, 72: 1 348-1 353
30. Mackay IR. Induction by drugs of hepatitis and autoantibodies to cell organelles significance and interpretation. Hepatology 1985, 5 904-906